|
|
|
|
|
|
|
|
|
|
|
|
|
KOMISJA NADZORU FINANSOWEGO |
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Raport bieżący nr |
3 |
/ |
2015 |
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
Data sporządzenia: |
2015-04-29 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
Skrócona nazwa emitenta |
|
|
|
|
|
|
|
|||
|
MILESTONE MEDICAL |
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
Temat |
|
|
|
|
|
|
|
|
|
|
|
Information on the date of the Shareholders Meeting of Milestone Medical Inc. |
|
|||||||||
|
Podstawa prawna |
|
|
|
|
|
|
|
|||
|
Art. 56 ust. 1 pkt 2 Ustawy o ofercie - informacje bie¿¹ce i okresowe |
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
Treść raportu: |
|
|
|
|
|
|
|
|
|
|
|
Puruant to Article 56, Section 1, item 2 of the Act on public Offering -current and periodical information.
|
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
Załączniki |
|
|
|
|
|
|
|
|
|
|
|
Plik |
Opis |
|
||||||||
|
|
|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MESSAGE (ENGLISH VERSION) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MILESTONE MEDICAL INC |
|
|
|||||||||
|
|
(pełna nazwa emitenta) |
|
|
|||||||||
|
|
MILESTONE MEDICAL |
|
|
|
|
|||||||
|
|
(skrócona nazwa emitenta) |
|
(sektor wg. klasyfikacji GPW w W-wie) |
|
|
|||||||
|
|
NJ 07039 |
|
. |
|
|
|||||||
|
|
(kod pocztowy) |
|
(miejscowość) |
|
|
|||||||
|
|
South Orange Avenue Livingston |
|
220 |
|
|
|||||||
|
|
(ulica) |
|
(numer) |
|
|
|||||||
|
|
+11 973 535 2717 |
|
+11 973 535 2829 |
|
|
|||||||
|
|
(telefon) |
|
|
(fax) |
|
|
||||||
|
|
|
|
|
|
|
|||||||
|
|
(e-mail) |
|
|
(www) |
|
|
||||||
|
|
27-5484393 |
|
|
|
|
|||||||
|
|
(NIP) |
|
|
(REGON) |
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PODPISY OSÓB REPREZENTUJĄCYCH SPÓŁKĘ |
|
|||
|
Data |
Imię i Nazwisko |
Stanowisko/Funkcja |
Podpis |
|
|
2015-04-29 |
Joseph D'Agostino |
Chief Financial Officer |
Joseph D'Agostino |
|
|
|
|
|
|
|